Guide to Glucose in Urine
Summary
Glucose in urine (glucosuria) usually occurs when there's too much glucose (sugar) in your blood for your kidneys to process. The excess glucose spills into the urine. This can be a sign of high blood sugar levels and diabetes. Testing for glucose in urine is a preliminary screening tool for diabetes.
Why It Matters
Urine typically contains very little or no glucose. Glucose circulates in your blood, and as blood passes through the kidneys, glucose gets captured and sent back into your bloodstream. But when there's too much glucose in the blood, it is excreted in urine. This is often a sign of diabetes.
Urine glucose testing is not as accurate as blood glucose testing for diabetes---it misses postprandial spikes and doesn't give time-based data, unlike a CGM or HbA1c--- so blood tests are more commonly used to diagnose and monitor diabetes. But it can be a helpful screening test.
It's also common to test glucose in urine in pregnant women. While some glucose during pregnancy is normal, elevated levels over time can be a sign of gestational diabetes.
Urine glucose tests are also sometimes used to screen for rare kidney problems that affect how the kidneys filter glucose in blood.
Clinical Ranges
Lab Reference Range: Negative
Symptoms of Conditions Associated with Glucose in Urine
While glucose in urine itself is a laboratory finding and doesn't directly cause symptoms, the underlying conditions it may indicate (particularly diabetes) can present with:
- Increased thirst and frequent urination (polyuria and polydipsia, potential signs of diabetes)
- Unexplained fatigue (can be due to cells not receiving enough glucose for energy)
- Blurred vision (may be caused by glucose-related damage in eye blood vessels)
- Slow-healing wounds (high blood sugar can impair healing processes)
- Recurring urinary tract infections (bacteria thrive in sugar-rich urine; especially relevant for women, who are more prone to UTIs)
- Unexplained weight loss (can occur when the body can't use glucose properly)
- Increased hunger (can occur as cells are starved of glucose despite high blood levels)
Lifestyle Factors That Can Impact It
Activities that can help maintain stable blood sugar levels and decrease the likelihood of glucose in urine include:
- Physical activity: Regular exercise improves insulin sensitivity and helps regulate blood glucose levels, reducing the risk of glucose in urine. Even moderate daily activity can have significant benefits.
- Sleep patterns: Maintaining consistent sleep schedules supports proper glucose regulation. Poor sleep can affect insulin sensitivity and glucose metabolism, potentially contributing to glycosuria.
Activities that may increase the likelihood of glucose in urine include:
- Dietary habits: A diet high in refined carbohydrates and sugars can cause blood sugar levels to rise. Following a balanced diet containing healthy fats, lean protein and complex carbohydrates helps maintain stable blood glucose levels.
- Stress management: Chronic stress can elevate blood glucose levels through the release of stress hormones, potentially leading to glucose in urine. Following stress-reduction techniques can help maintain healthy glucose levels.
Other Factors That Can Impact It
Genetic Conditions
- Mutations in a specific gene can cause glucose in urine
- A family history of diabetes increases the risk of developing the condition
Medical Conditions
- Diabetes: A metabolic disorder where the body's insulin production is impaired (Type 1) or the body doesn't utilize it properly(Type 2), leading to elevated blood glucose.
- Cushing's syndrome: Excessive cortisol production affects glucose metabolism and can cause insulin resistance, increasing blood glucose levels
- Pancreatitis: Inflammation of the pancreas can impair insulin production, affecting glucose regulation.
- Gestational diabetes: Pregnancy-related diabetes that can cause a temporary rise in blood sugar levels.
- Hyperthyroidism: The thyroid produces excess hormones, causing the liver to overproduce glucose.
Medications and Supplements
- Corticosteroids
- Some antipsychotic medications may raise blood glucose and lead to urine excretion
- Certain diuretics can impair insulin secretion and response, resulting in elevated glucose
- Beta-blockers may block insulin release and raise glucose
- SGLT2 inhibitors (a medication for treating Type 2 diabetes) can lead to glucose in the urine, but this means the medication is working as intended
Individual Factors
- Age: The body becomes less efficient at handling glucose with age
- Pregnancy: Can lower kidney threshold for glucose
- Body weight: Obesity can contribute to insulin resistance and increased glucose levels
- Hormonal changes: Can affect glucose metabolism
Testing Accuracy and Stability
Factors That Can Affect the Accuracy of Your Test
- Recent antibiotic use can lead to false positives and false negatives, depending on the type of antibiotic
- Eating before urinalysis can increase glucose in urine
- Dehydration increases urine concentration and glucose
- Some vitamin C supplements can interfere with results
How it Relates to Other Markers
Your healthcare providers will likely order other tests to diagnose you. Some other tests they might look at include:
- Fasting blood glucose: Provides direct measurement of blood glucose levels after an 8-12 hour fast.
- HbA1C: Measures average blood glucose levels over the past 2-3 months, offering insight into long-term glucose control.
- Kidney function tests: Including creatinine and BUN to evaluate possible kidney dysfunction.
- Oral glucose tolerance test: This test helps diagnose metabolic disorders like gestational diabetes and prediabetes by measuring how well the body processes glucose.
What Results May Mean in the Context of Other Markers
- Glucose in urine with elevated fasting blood glucose or elevated HbA1C: May indicate diabetes.
- Glucose in urine without elevated blood glucose but with abnormal kidney markers: Could suggest proximal tubule dysfunction (Fanconi syndrome)
- Glucose in urine with abnormal kidney function tests: May signal diabetic kidney disease or another form of kidney dysfunction.
- Glucose in urine with abnormal oral glucose tolerance test: Can suggest impaired glucose metabolism.
Follow-up Considerations
If your urine glucose levels are high, your provider may consider these follow-ups. You should always speak to your doctor if you have medical questions or before making medical decisions.
When Re-Testing May be Appropriate
- Every 3-6 months if diagnosed with diabetes with risk factors, such as obesity, family history, polycystic ovarian syndrome (PCOS), or prior gestational diabetes.
- During each prenatal visit for pregnant women
- Annually or as directed by your provider for those with risk factors such as chronic kidney disease
Additional Testing Your Doctor May Consider
- Comprehensive metabolic panel
- Insulin levels
- C-peptide test (a protein produced with insulin)
- Autoantibody testing for Type 1 diabetes
When Additional Care May be Warranted
- Persistent glucose in urine despite lifestyle changes
- Symptoms of diabetes
- During pregnancy with positive glucose readings
- Unexplained weight loss
- Frequent urinary tract infections
Bibliography
References
1. Reed, Beverly G., and Bruce R. Carr. "The Normal Menstrual Cycle and the Control of Ovulation." Endotext, edited by Kenneth R. Feingold et al., MDText.com, Inc., 2018.
2. Kumar, Pratap, and Sameer F. Sait. "Luteinizing Hormone and Its Dilemma in Ovulation Induction." Journal of Human Reproductive Sciences, vol. 4, no. 1, 2011, pp. 2-7. DOI: 10.4103/0974-1208.82351.
3. Practice Committee of the American Society for Reproductive Medicine. "Diagnostic Evaluation of the Infertile Male: A Committee Opinion." Fertility and Sterility, vol. 103, no. 3, 2015, pp. e18-e25. DOI: 10.1016/j.fertnstert.2014.12.103.
4. Barbieri, Robert L. "The Endocrinology of the Menstrual Cycle." Methods in Molecular Biology, vol. 1154, 2014, pp. 145-169. DOI: 10.1007/978-1-4939-0659-8_7.
5. Orlowski, M., and M. S. Sarao. "Physiology, Follicle Stimulating Hormone." StatPearls, StatPearls Publishing, 2023.
6. MedlinePlus. "Follicle-Stimulating Hormone (FSH) Levels Test." MedlinePlus, National Library of Medicine (US), 4 Dec. 2023.
7. Labrie, Fernand, et al. "Is Dehydroepiandrosterone a Hormone?" Journal of Endocrinology, vol. 187, no. 2, 2005, pp. 169-196. DOI: 10.1677/joe.1.06128.
8. Orentreich, Norman, et al. "Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood." The Journal of Clinical Endocrinology & Metabolism, vol. 59, no. 3, 1984, pp. 551-555. DOI: 10.1210/jcem-59-3-551.
9. Handelsman, David J., and Leonard Wartofsky. "Requirement for Mass Spectrometry Sex Steroid Assays in the Journal of Clinical Endocrinology and Metabolism." The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 10, 2013, pp. 3971-3973. DOI: 10.1210/jc.2013-3375.
10. Savineau, Jean-Pierre, et al. "Role of DHEA in Cardiovascular Diseases." Biochemical Pharmacology, vol. 85, no. 6, 2013, pp. 718-726. DOI: 10.1016/j.bcp.2012.11.015.
11. Rainey, William E., and Yoshimi Nakamura. "Regulation of the Adrenal Androgen Biosynthesis." The Journal of Steroid Biochemistry and Molecular Biology, vol. 108, no. 3-5, 2008, pp. 281-286. DOI: 10.1016/j.jsbmb.2007.09.012.
12. Baulieu, Etienne-Emile, et al. "Dehydroepiandrosterone (DHEA), DHEA Sulfate, and Aging: Contribution of the DHEAge Study to a Sociobiomedical Issue." Proceedings of the National Academy of Sciences, vol. 97, no. 8, 2000, pp. 4279-4284. DOI: 10.1073/pnas.97.8.4279.
13. Shufelt, Chrisandra, et al. "DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health---National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)." The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 11, 2010, pp. 4985-4992. DOI: 10.1210/jc.2010-0558.
14. Traish, Abdulmaged M., et al. "Dehydroepiandrosterone (DHEA)---A Precursor Steroid or an Active Hormone in Human Physiology." The Journal of Sexual Medicine, vol. 8, no. 11, 2011, pp. 2960-2972. DOI: 10.1111/j.1743-6109.2011.02404.x.
15. Maggio, Marcello, et al. "DHEA and Cognitive Function in the Elderly." The Journal of Steroid Biochemistry and Molecular Biology, vol. 145, 2015, pp. 281-292. DOI: 10.1016/j.jsbmb.2014.05.003.
16. Stárka, Luboslav, et al. "Dehydroepiandrosterone: A Neuroactive Steroid." The Journal of Steroid Biochemistry and Molecular Biology, vol. 145, 2015, pp. 254-260. DOI: 10.1016/j.jsbmb.2014.05.007.
17. Baird, Donna T., et al. "Measurement of Estradiol in Women of Reproductive Age---Pitfalls and Cautions." Frontiers in Endocrinology, vol. 10, 2019, article 93. DOI: 10.3389/fendo.2019.00093.
18. Burger, Henry G. "Androgen Production in Women." Fertility and Sterility, vol. 77, suppl. 4, 2002, pp. S3-S5. DOI: 10.1016/S0015-0282(02)02985-0.
19. Fogle, Robert H., et al. "Serum Testosterone Levels in Women During Reproductive Aging: The Transition Experience." The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 3, 2007, pp. 747-751. DOI: 10.1210/jc.2006-1744.
20. Hankinson, Susan E., et al. "Circulating Concentrations of Insulin-Like Growth Factor-I and Risk of Breast Cancer." The Lancet, vol. 351, no. 9113, 1998, pp. 1393-1396. DOI: 10.1016/S0140-6736(97)10384-1.
21. Haring, Robin, et al. "Age-Specific Reference Ranges for Serum Testosterone and Androstenedione Concentrations in Women Measured by Liquid Chromatography--Tandem Mass Spectrometry." The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 2, 2012, pp. 408-415. DOI: 10.1210/jc.2011-2134.
22. Rosenfield, Robert L., et al. "Evidence That the Degree of Postpubertal Hyperandrogenism Is the Result of an Interaction Between Prenatal and Postpubertal Androgen Excess in a Random Population of Women." The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 8, 2015, pp. 2857-2868. DOI: 10.1210/jc.2015-1753.
23. Stanczyk, Frank Z., et al. "Interrelationships of Testosterone and Estradiol Levels with Sex Hormone-Binding Globulin and Body Mass Index in Reproductive Age Women Without Hyperandrogenism." Fertility and Sterility, vol. 98, no. 1, 2012, pp. 102-108. DOI: 10.1016/j.fertnstert.2012.04.001.




